Funding for this research was provided by:
Received: 17 August 2017
Accepted: 8 April 2018
First Online: 25 April 2018
Ethics approval and consent to participate
: The study was conducted according to protocols approved by local institutional review board in accordance with the Declaration of Helsinki. The present study was performed using patient material from the Nordic MCL2 and MCL3 trials, all patients have given informed consent to the biobanking and the analysis of molecular markers on tumor tissue, approved by the Ethics committee in Uppsala, Sweden, Dnr 428/2009.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.